Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
The Iran war continues without a clear end, and financial market participants are beginning to consider a scenario where the conflict extends over months rather than weeks, according to an Ebury analysis.
Olympus Foods România has begun construction of a new warehouse at its Brașov Dairy Factory, with an investment of €7.5 million.
Romanians are spending more on cinema experiences as economic pressures drive a shift towards leisure-oriented consumption. Cinema revenues reached approximately €63 million in 2025, up 16% compared to 2024 and around 10% above pre-pandemic levels, according to Colliers data.
Affidea Romania continues its expansion plan in integrated medical services and announces the acquisition of five centres: Phoenix clinics in Bucharest, Arad, Sf. Gheorghe, Sighetu Marmaţiei and GMH Clinic in the capital. The Affidea network now reaches 81 clinics in 33 cities.
Although 86% of organisations plan to increase their artificial intelligence (AI) investments, only 18% can fully leverage this technology, according to an Accenture report.